BMRN vs SGN · P/E 40, rev $1.76B vs rev $615.6K
Biomarin Pharmaceutical Inc (BMRN) versus Signing Day Sports, Inc. (SGN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Signing Day Sports, Inc. (SGN) is a software - application company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SGN revenue for 2024-12-31 was $615.6K. Net income was -$8.7M. Revenue was up 100.1% from 2023-12-31 to 2024-12-31. SGN currently screens at market cap $7.4M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SGN currently screens at market cap $7.4M.
Not investment advice. Open the BMRN and SGN stock pages for the full models.
Not investment advice.